Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-21

Clinical Trial Update: Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing liraglutide to insulin mono-therapy in a closed-loop setting for Type 1 Diabetes; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)
  • liraglutide (liraglutide)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2018-08-21